These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31469483)

  • 1. Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency.
    Saes JL; Schols SEM; Betbadal KF; van Geffen M; Verbeek-Knobbe K; Gupta S; Hardesty BM; Shapiro AD; van Heerde WL
    Haemophilia; 2019 Nov; 25(6):1073-1082. PubMed ID: 31469483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency.
    van Geffen M; Cugno M; Lap P; Loof A; Cicardi M; van Heerde W
    Clin Exp Immunol; 2012 Mar; 167(3):472-8. PubMed ID: 22288590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited disorders of the fibrinolytic pathway.
    Jain S; Acharya SS
    Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.
    Matsumoto T; Nogami K; Shima M
    Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury.
    Tucker TA; Jeffers A; Alvarez A; Owens S; Koenig K; Quaid B; Komissarov AA; Florova G; Kothari H; Pendurthi U; Mohan Rao LV; Idell S
    Am J Respir Cell Mol Biol; 2014 Feb; 50(2):316-27. PubMed ID: 24024554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders.
    Van Geffen M; Menegatti M; Loof A; Lap P; Karimi M; Laros-van Gorkom BA; Brons P; Van Heerde WL
    Haemophilia; 2012 Jul; 18(4):630-8. PubMed ID: 22404435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor type 1 deficiency.
    Mehta R; Shapiro AD
    Haemophilia; 2008 Nov; 14(6):1255-60. PubMed ID: 19141166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
    Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
    Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 deficiency suppresses osteoblastic differentiation of mesenchymal stem cells in mice.
    Takafuji Y; Tatsumi K; Ishida M; Kawao N; Okada K; Matsuo O; Kaji H
    J Cell Physiol; 2019 Jun; 234(6):9687-9697. PubMed ID: 30387130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
    Wiewel-Verschueren S; Knol HM; Lisman T; Bogchelman DH; Kluin-Nelemans JC; van der Zee AG; Mulder AB; Meijer K
    J Thromb Haemost; 2014 Sep; 12(9):1488-93. PubMed ID: 24954113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.
    Labarrere CA; Pitts D; Halbrook H; Faulk WP
    Circulation; 1994 Apr; 89(4):1599-608. PubMed ID: 8149527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma-based assays distinguish hyperfibrinolysis and shutdown subgroups in trauma-induced coagulopathy.
    Lawson MA; Holle LA; Dow NE; Hennig G; de Laat B; Moore HB; Moore EE; Cohen MJ; Bouchard BA; Freeman K; Wolberg AS
    J Trauma Acute Care Surg; 2022 Nov; 93(5):579-587. PubMed ID: 35687811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
    Agren A; Wiman B; Schulman S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of factor XIa on thrombin and plasmin generation, clot formation, lysis and density in coagulation factors deficiencies.
    Tarandovskiy ID; Ovanesov MV
    Thromb Res; 2024 Jan; 233():189-199. PubMed ID: 38101192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four cases of bleeding diathesis in children due to congenital plasminogen activator inhibitor-1 deficiency.
    Minowa H; Takahashi Y; Tanaka T; Naganuma K; Ida S; Maki I; Yoshioka A
    Haemostasis; 1999; 29(5):286-91. PubMed ID: 10754381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of plasminogen activator inhibitor activity by plasmin in endothelial cells.
    Shi GY; Wang SJ; Chang B; Tasi CF; Lin MT; Chang WC; Wing LY; Jen CJ; Wu HL
    Thromb Res; 1996 Jan; 81(1):75-84. PubMed ID: 8747522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.
    Jönsson Rylander AC; Lindgren A; Deinum J; Bergström GM; Böttcher G; Kalies I; Wåhlander K
    J Thromb Haemost; 2017 Apr; 15(4):758-769. PubMed ID: 28135035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary partial deficiency of plasminogen activator inhibitor-1 associated with a lifelong bleeding tendency.
    Takahashi Y; Tanaka T; Minowa H; Ookubo Y; Sugimoto M; Nakajima M; Miyauchi Y; Yoshioka A
    Int J Hematol; 1996 Jul; 64(1):61-8. PubMed ID: 8757969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.